Artificial Intelligence and Pulmonary Fibrosis: International Pulmonology Forum 2026

I am delighted to share my enthusiasm for my upcoming participation, as a speaker and moderator, in the 24th International Forum of Pulmonology, to be held in Milan on 13 and 14 March 2026.

This year, the event focuses on a topic of vital importance for the future of our discipline: “Artificial and non-artificial intelligence in support of pulmonology”.

As a member of the Forum's Faculty, I will be involved in two crucial moments of the scientific programme, both focused on interstitial lung diseases, particularly fibrosis.

The management of IPF and PPF: A New Beginning?

On Saturday 14 March, I will have the honour of giving Lecture 7: “MANAGING IPF AND PPF: A NEW BEGINNING?”. Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are complex challenges, but advances in therapies and diagnostic approaches are opening up new perspectives.

We will discuss the latest advances, with the aim of making care for patients with these diseases increasingly timely, effective and personalised.

World Café: Progressive Pulmonary Fibrosis

Also on Saturday, I will participate in an important World Café. Together with my colleagues G. Carrafiello, S. Bosello and G. Sgalla, we will address the topic: ‘Progressive Pulmonary Fibrosis: one case, multiple perspectives’.

This interactive format will allow us to analyse a clinical case from different angles – from radiology to clinical experience – highlighting the importance of a multidisciplinary approach in the management of these rare and complex diseases.

Artificial Intelligence as an ally

The 2026 Forum aims to explore how Artificial Intelligence is transforming the diagnosis, treatment and management of respiratory diseases. AI is set to become an indispensable ally in medicine, and its impact on complex respiratory diseases, such as interstitial lung diseases, will be central to the discussions.

I am convinced that the combination of advanced technology and human judgement, creating a synergy between clinical experience and AI, is the way forward for the future of pulmonology.

I look forward to seeing you in Milan, at the Grand Visconti Palace Hotel, on 13 and 14 March, for a scientific debate of the highest level.